Technical Analysis for OBIO - Orchestra BioMed Holdings, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 4.45 | 0.23% | 0.01 |
OBIO closed down 0.89 percent on Thursday, April 25, 2024, on 1.31 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 0.23% | |
| Doji - Bullish? | Reversal | 0.23% | |
| New 52 Week Low | Weakness | 0.23% | |
| BB Squeeze + Lower Band Touch | Range Contraction | 0.23% | |
| Lower Bollinger Band Touch | Weakness | 0.23% | |
| Oversold Stochastic | Weakness | 0.23% | |
| 180 Bearish Setup | Bearish Swing Setup | -0.67% | |
| Bollinger Band Squeeze | Range Contraction | -0.67% | |
| Outside Day | Range Expansion | -0.67% | |
| Gapped Down | Weakness | -0.67% |
| Alert | Time |
|---|---|
| 10 DMA Resistance | about 2 hours ago |
| 60 Minute Opening Range Breakout | about 3 hours ago |
| Rose Above Previous Day's High | about 3 hours ago |
| Up 3% | about 3 hours ago |
| Up 2% | about 3 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Orchestra BioMed, Inc. operates as a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases. It offers BackBeat Cardiac Neuromodulation Therapy (CNT), a patented, intelligent bioelectronic treatment for hypertension; Virtue SAB, a patented drug/device combination product for the treatment of artery disease; FreeHold Retractors, a minimally invasive surgical device solution; and Virtue SEB, a drug-eluting balloon angioplasty system for the treatment of coronary artery disease. Orchestra BioMed, Inc. has a strategic collaboration with Medtronic to develop BackBeat CNT as a potential treatment for hypertension in patients who are indicated for a cardiac pacemaker. The company was incorporated in 2017 and is based in New Hope, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Hypertension Cardiovascular Disease Neuromodulation Artery Disease Coronary Artery Disease Angioplasty Medtronic
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Hypertension Cardiovascular Disease Neuromodulation Artery Disease Coronary Artery Disease Angioplasty Medtronic
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 20.04 |
| 52 Week Low | 4.22 |
| Average Volume | 42,450 |
| 200-Day Moving Average | 6.59 |
| 50-Day Moving Average | 5.49 |
| 20-Day Moving Average | 4.80 |
| 10-Day Moving Average | 4.63 |
| Average True Range | 0.32 |
| RSI (14) | 31.03 |
| ADX | 27.39 |
| +DI | 10.77 |
| -DI | 23.38 |
| Chandelier Exit (Long, 3 ATRs) | 4.74 |
| Chandelier Exit (Short, 3 ATRs) | 5.18 |
| Upper Bollinger Bands | 5.24 |
| Lower Bollinger Band | 4.37 |
| Percent B (%b) | 0.08 |
| BandWidth | 18.04 |
| MACD Line | -0.30 |
| MACD Signal Line | -0.31 |
| MACD Histogram | 0.0107 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.97 | ||||
| Resistance 3 (R3) | 4.95 | 4.76 | 4.88 | ||
| Resistance 2 (R2) | 4.76 | 4.63 | 4.77 | 4.85 | |
| Resistance 1 (R1) | 4.60 | 4.54 | 4.62 | 4.62 | 4.82 |
| Pivot Point | 4.41 | 4.41 | 4.42 | 4.42 | 4.41 |
| Support 1 (S1) | 4.25 | 4.28 | 4.27 | 4.27 | 4.06 |
| Support 2 (S2) | 4.06 | 4.19 | 4.07 | 4.03 | |
| Support 3 (S3) | 3.90 | 4.06 | 4.00 | ||
| Support 4 (S4) | 3.92 |
